medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Número 1

<< Anterior Siguiente >>

Salud Mental 2014; 37 (1)


Remisión sintomática y recuperación funcional en pacientes que padecen esquizofrenia

Valencia M, Caraveo J, Colin R, Verduzco W, Corona F

Idioma: Español
Referencias bibliográficas: 151
Paginas: 59-74
Archivo PDF: 458.25 Kb.


RESUMEN

Recientemente los conceptos de remisión sintomática y recuperación funcional en los pacientes que padecen esquizofrenia han recibido una considerable atención por parte de los clínicos y los investigadores. El interés en estos aspectos tiene que ver con la propuesta realizada en el 2005 por el “Grupo de trabajo para evaluar la remisión en esquizofrenia”, con el objetivo de proponer una definición de remisión sintomática, así como el desarrollo de criterios operacionales para su evaluación. La remisión sintomática se evalúa utilizando ocho reactivos de la escala PANSS, los cuales deben puntuar tres o menos, con una duración mínima de seis meses de remisión. En Europa, desde el 2006, también se han propuesto criterios para evaluar la respuesta al tratamiento, así como la remisión sintomática. La remisión se puede evaluar usando una fórmula para calcular el porcentaje de reducción de síntomas desde el inicio del tratamiento de acuerdo al PANSS.
También se han desarrollado criterios para evaluar la recuperación funcional que incluyen la combinación de aspectos clínicos y psicosociales, que se deben mantener por lo menos por dos años consecutivos, incluyendo dimensiones como el funcionamiento psicosocial, el funcionamiento cognitivo y la calidad de vida. En el presente artículo se revisa la investigación respecto a los conceptos de remisión sintomática y recuperación funcional en los pacientes afectados por esta patología, incluyendo estudios clínicos, epidemiológicos, estudios de revisión y meta-análisis publicados entre enero de 1970 a julio de 2013. Se incluyeron 62 estudios sobre remisión sintomática/ recuperación funcional, con un total de 94 940 pacientes, con un seguimiento de seis meses a 37 años. También se incluyeron 32 estudios de recuperación funcional, con un total de 6 483 pacientes, con un seguimiento de dos a 42 años. Los resultados indican que entre el 20 y el 97% de los pacientes pueden lograr la remisión sintomática, mientras que entre el 10 y el 68% alcanzan la recuperación funcional. Se ha recomendado el uso de estos criterios en la práctica clínica y en la investigación científica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lieberman J, Stroup S, McEvoy JP, Swartz M et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England J Medicine 2005;353(12):1209-1223.

  2. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63(12):1121-1128.

  3. Mueller N. Mechanism of relapse prevention in schizophrenia. Pharmacopsychiatry 2004;37(Supl 2):S141-S147.

  4. Mccann TV, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J Psychiatr Ment Health Nurs 2008;15:622-629.

  5. Torgalsboen AK, Rishov B. Maintenance of recovery from schizophrenia at 2’-year follow-up: what happened? Psychiatry 2010;73(1):70-83.

  6. Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiologia e Psichiatria Sociale 2008;17(2):128-137.

  7. Lambert M, Schimmelmann BG, Naber D, Schacht A et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006;67:1690-1697.

  8. van Os J, Drukker M, Campo J, Meijer J et al. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006;163:2000-2002.

  9. Stahl S, Buckley P. Negative symptoms of Schizophrenia: a problem that will not go away. Acta Psychiatr Scand 2007;7:6-11.

  10. Asociación Psiquiátrica Americana, DSM-IV. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Barcelona: Masson, SA; 1995.

  11. Mueser K. Cognitive functioning, social adjustment and long-term outcome in schizophrenia. Cognition in schizophrenia. Tonmoy Sharma T, Harvey Ph(ed). Oxford University Press: 2000.

  12. Rossler W, Haug HJ, Jorgensen PM. The psychosocial basis of schizophrenia Acta Psychiatr Scand 2000;102(Supl.407):1-99.

  13. Bellack A, Mueser K. Psychosocial treatment for schizophrenia. Schizophr Bull 1993;19:317-336.

  14. Lehman A, Kreyenbuhl J, Buchanan R et al. The Schizophrenia patient outcomes research team (PORT): Updated treatment Recommendations 2003. Schizophr Bull 2004;30(2):197-217.

  15. Valencia M, Rascón ML, Juárez F, Murow E. A psychosocial skills training approach in Mexican out-patients with schizophrenia. Psychol Med 2007;37:1393-1402.

  16. Liberman RP. Recovery from disability Manual of Psychiatric Rehabilitation. Washington, DC: American Psychiatric Publishing, Inc; 2008.

  17. Valencia M, Rascón ML, Juárez F, Escamilla R et al. Application in Mexico of psychosocial rehabilitation with schizophrenia patients. Psychiatry 2010;73(3):248-263.

  18. Mueser KT, Deavers F, Penn DL, Cassisi JE. Psychosocial treatments for Schizophrenia. Annual Review Clinical Psychology 2013;9:465-497.

  19. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 1997;154 (supl. abril):1-63.

  20. Torrey W, Drake R, Dixon L, Burns B et al. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv 2001;52(1):45-50.

  21. Bustillo J, Lauriello J, Horan W, Keith S. The psychosocial treatment of schizophrenia: an update. Am J Psychiatry 2001;158:163-175.

  22. Thornicroft G, Susser E. Evidence-based psychotherapeutic interventions in the community care of schizophrenia. Br J Psychiatry 2001;178:2-4.

  23. Lehman A, Steinwachs D. Evidence-based psychosocial treatment practice in schizophrenia: Lessons from the patient outcomes research team (PORT) project. J American Academy Psychoanalysis Dynamic Psychiatry 2003;31(1):141-154.

  24. Falloon I, Montero I, Sungur M, Mastroeni A et al. Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment. World Psychiatry 2004;3(2):104-109.

  25. McGurk SR, Mueser KT, DeRosa J, Wolfe R. Work, recovery, and comorbidity in schizophrenia: A randomized controlled trial of cognitive remediation. Schizophr Bull 2009;35(2):319-335.

  26. Shean DG. Evidence-based psychosocial practice and recovery from schizophrenia. Psychiatry 2009;72(4):307-320.

  27. Dixon L, Dickerson F, Bellack A. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010;36(1):48-70.

  28. Liberman R, Kopelowicz A. Recovery from schizophrenia: A concept in search of research. Psychiatr Serv 2005;56(6):735-742.

  29. Kruger A. Schizophrenia: Recovery and hope. Psychiatric Rehabilitation J 2000;24(1):29-37.

  30. Nasrallah H. Is Schizophrenia recovery a myth? Curr Psychiatry 2008;7:5:19-20.

  31. Martens W. Recovery from schizophrenia: Fact or fiction? Long-term remission is unusual, but comprehensive therapy may improve the odds. Curr Psychiatry 2004;3(7):19-30.

  32. Andreasen N, Carpenter W, Kane J. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441-449.

  33. Tohen M, Strakowski SM, Zarate C, Hennen J et al. The McLean- Harvard first-episode project: 6- month symptomatic and functional outcome in affective and non-affective psychosis. Biol Psychiatry 2000;48(6):467-476.

  34. Kane J. An evidence-based strategy for remission in schizophrenia. J Clin Psychiatry 2008;69(Supl 3):25-30.

  35. Harrison G, Hopper K, Craig T. Recovery from psychotic illness: a 15 –and 25 year international follow-up study. Br J Psychiatry 2001;178:506-517.

  36. Spaniol L, Wewiorski N, Gagne C, Anthony WA. The process of recovery from schizophrenia. Int Rev Psychiatry 2002;14(4):327-336.

  37. Resnick S, Rosenheck R, Lehman A. An exploratory analysis of correlates of recovery. Psiquiatr Serv 2004;55(5):540-547.

  38. Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull 2009;35(2):300-306.

  39. Yeomans D, Taylor M, Currie A, Whale R. Resolution and remission in schizophrenia: getting well and staying well. Advances Psychiatric Treatment 2010;16:86-95.

  40. Kay S, Fiszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.

  41. Overall JE, Gorham OR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.

  42. Andreasen NC, Olsen S. Negative and positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-794.

  43. Leucht S, Davis J, Engel R et al. Definitions of response and remission in schizophrenia: recommendations for their use and their presentations for their use and their presentation. Acta Psychiatr Scand 2009;119(supl.438):7-14.

  44. Leucht S, Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006;39:161-170.

  45. Leucht S, Davis J, Engel R, Kane JM et al. Defining response in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007;32:1903-1910.

  46. van Os J, Cavallaro R, Leucht S, Peuskens J et al. Standardized remission criteria in schizophrenia Acta Psychiatr Scand 2006;113:91-95.

  47. Wang L, Liu W, Van H. A comparative trial of the efficacy of olanzapine and chlorpromazine in treatment resistant schizophrenia. J Health Psychology 2004;12:203-204.

  48. Figueira ML, Brissos S. Measuring psychosocial outcomes in schizophrenia patients. Curr Op Psychiatry 2011;24:90-99.

  49. Emsley R, Chiliza B, Asmal L, Lehloenya K. The concepts of remission and recovery in schizophrenia. Curr Op Psychiatry 2011;24:114-121.

  50. Weiden P, Zygmunt A. Medication noncompliance in schizophrenia: part I. Assessment J Practice. Psychiatry Behavioral Health 1997;3:106-110.

  51. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 2004;161(2):2-56.

  52. Davidson L, Roe D. Recovery from versus recovery in serious mental illness: one strategy for lessening plaguing recovery. J Mental Health 2007;16:1-12.

  53. Davidson L, O´Connell M, Tondora J, Styron T et al. The top ten concerns about recovery encountered in mental health system transformation. Psychiatr Serv 2006;57(5):640-645.

  54. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-followup study. Schizophr Bull 2005;31(3):723-734.

  55. Schrank B, Slade M. Recovery in psychiatry. Psychiatric Bull 2007;31: 321-325.

  56. Whitehorn D, Brown J, Richard, Rui Q et al. Multiple dimensions of recovery in early Psychosis. Int Rev Psychiatry 2002;14(4):273-283.

  57. Harding CM, Brooks GW, Ashikaga T et al. The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727-735.

  58. Torgalsboen AK. Full recovery from schizophrenia: The prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender. Psychiatry Res 1999;88:142-152.

  59. Bobes J, Ciudad A, Álvarez E, San L et al. Recovery from schizophrenia: results from a 1-year follow-up pbservational study of patients in symptomatic remission. Schizophr Res 2009;115:58-66.

  60. San L, Ciudad A, Álvarez E, Bobes J et al. Symptomatic remission and social/ vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry 2007;22:490-498.

  61. Asociación Psiquiátrica Americana, DSM-IV. Escala de evaluación de la actividad global- EEAG-GAF. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Barcelona: Masson, SA; 1995.

  62. Kopelowicz A, Liberman RP, Ventura J, Zarate R et al. Neurocognitive correlates of recovery from schizophrenia. Psychol Med 2005;35:1165-1173.

  63. Stephens JH, Richard P, McHugh PR. Long-term follow-up of patients hospitalized for schizophrenia, 1913-1940. J Nervous ental Disease 1997;185:715-721.

  64. Kiriakakis V, Bhatia HP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998;121(11):2053-2066.

  65. Mala E. Early onset schizophrenia. Czek Psychiatry 1993;89(5):259-271.

  66. Modestin J, Huber A, Satiri E, Malti T et al. Long-term course of schizophrenia illness: Bleuler´s study reconsidered. Am J Psychiatry 2003;160:2202-2208.

  67. Fresan A, Apiquian R, Loyzaga C et al. Recuperación funcional en el primer episodio psicótico. Psiquiatría Salud Integral 2002;marzo/abril:40-44.

  68. Valencia M, Rojas E, González C, Ramos L et al. Evaluación del funcionamiento psicosocial en pacientes de un Centro de Salud. Salud Pública México 1989;31(5):674-687.

  69. Valencia M, Juarez F, Ortega H. Integrated treatment to achieve functional recovery for first-episode psychosis. Schizophrenia Research Treatment 2012; DOI(10.1155).

  70. Valencia M, Fresan A, Juárez F, Escamilla R et al. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia. J Psychiatric Research 2013 (en prensa).

  71. Song LY, Shih CY. Factors process and outcomes of recovery from psychiatric disability: the unity model. Int J Soc Psychiatr 2009;55(4):348-360.

  72. Mausbach BT, Moore R, Bowie C. A review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophr Bull 2009;35:307-318.

  73. Kern RS, Glynn SM, Horan WP, Marder S. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull 2009;35(2):347-361.

  74. Lysaker PH, Glyin SM. Psychotherapy and recovery from schizophrenia. Psychol Serv 2010;7:75-91.

  75. Shrivastava A, Johnston M, Shah N, Bureau Y. Redefining measures in schizophrenia: integrating social and clinical parameters. Curr Op Psychiatry 2010;23:120-126.

  76. Houghton J. Maintaining mental health in a turbulent world. Schizophr Bull 1982;8:548-552.

  77. Leete E. How I perceive and manage my illness. Schizophr Bull 1989;15:197-198.

  78. Unzicker R. On my own: A personal journey through madness and re-emergence. Psychosocial Rehabilitation J 1989;13:70-77.

  79. Fenley G. Compliance and recovery. Clinical Schizophrenia Related Psychoses 2008;12(3):262-263.

  80. Deegan PE. Recovery: the lived experience of rehabilitation. Psychosocial Rehabilitation J 1988;11:11-19.

  81. Anthony W, Cohen M, Farkas M, Gagne C. Psychiatric rehabilitation. Segunda edición. Boston: Boston University; 2002.

  82. Opler M, Yang LW, Caleo S, Alberti P. Statistical validation of criteria for symptom remission in schizophrenia: Preliminary findings. BMC Psychiatry 2007;7(35):1-7.

  83. Farkas M. The vision of recovery today: what it is and what it means for services. World Psychiatry 2007;2(2):68-74.

  84. Mueser K, Corrigan P, Hilton D et al. Illness management and recovery: A review of the research. Psychiatr Serv 2002;5:3-10.

  85. O´Hagan M. Recovery in New Zealand: Lessons for Australia? Australian e-Journal Advancement Mental Health 2004;3(1):1-3.

  86. Bellack A. Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications. Schizophr Bull 2006; 32(3):432-442.

  87. National Institute for Mental Health in England. Emerging Best Practices in Mental Health Recovery. NIMHE: London. 2004.

  88. Mueser K, Meyer P, Penn D, Clancy R, et al. The Illness Management and Recovery Program: Rationale, Development, and Preliminary Findings. Schizophr Bull 2006; 32(S1):S32-S43.

  89. Glynn S, Cohen A, Dixon L, Niv N. The Potential Impact of the Recovery Movement on Family Interventions for Schizophrenia: Opportunities and Obstacles. Schizophr Bull 2006; 32(3):451-463.

  90. Bleuler M. A 23- year longitudinal study of 208 schizophrenics and impressions in regard to the nature of Schizophrenia, in The Transmission of Schizophrenia. Edited by Rosenthal D, Kety SS. Pergamon, Oxford; 1968.

  91. Tsuang M, Woolson RF, Fleming J. Long-term outcome of major psychoses: I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch Gen Psychiatry 1979;36(12):1295-1301.

  92. Huber G, Gross G, Schuttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980;6:592-605.

  93. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606-618.

  94. Ogawa K, Miya M, Watarai A, Nakazawa M et al. A long –term followup study ofschizophrenia in Japan with special reference to the course of social adjustment. Br J Psychiatry 1987;151:758-765.

  95. Loebel AD, Lieberman JA , Alvir JM. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.

  96. Hegarty JD, Baldessarini RJ, Tohen M. One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-1416.

  97. Lieberman J, Jody D, Geisler S et al. Time course and biological correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376.

  98. DeSisto MJ, Harding CM, McCormick RV et al. The Maine and Vermont three decade studies of mental illness. II. Longitudinal course comparisons. Br J Psychiatry 1995;167:338-342.

  99. McGorry PD, Edwards J, Mihalopoulos C et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-326.

  100. Edwards J, Maude D, MacGorry PD, Harrigan S et al. Prolonged recovery in first- episode psychosis. Br J Psychiatry 1996;172 (supl 33):107-116.

  101. Hoffman H, Kupper Z. Facilitators of psychosocial recovery from schizophrenia. Int Rev Psychiatry 2002;14:293-302.

  102. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A et al. symptomatic and functional recovery from a first-episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473- 479.

  103. Haro JM, Novick D, Suarez D, Alonso J et al. and the SOHO study group. Remission and relapse in the outpatient care of schizophrenia three-year results from the schizophrenia outpatient health outcomes study. J Clinical Psychopharmacology 2006;26:571-578.

  104. Hellding L, Kane JM, Karilampi U, Norlander T et al. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorder Schizophr Res 2007;93:160-168.

  105. Holthausen EA, Wiersma D, Cahn W, Kahn RS et al. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res 2007;149:71-80.

  106. Lambert M, Naber D, Schacht A, Wagner T et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand 2008;118:220-229.

  107. Emsley R, Oosthuizen P, Koen L, Niehaus DJH et al. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int Clin Psychopharmacology 2008;23:325-331.

  108. Addington J, Addinton D. Symptom remission in first episode patients. Schizophr Res 2008;106(2-3):281-285.

  109. Eberhard J, Levander S, Lindström E. Remission in schizophrenia: analysis in naturalistic setting. Comp Psychiatry 2009;50:200-208.

  110. Boter H, Peuskens J, Libiger J, Wolfgang W et al. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res 2009;115:97-103.

  111. Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull 2009;35(2):362-369.

  112. Zimmermann J, Wolter A, Hannöver W, Krischke N. Frequency of remission in schizophrenia patients at one year follow-up. Psychiatrische Praxis 2009:36(4):182-188.

  113. Potkin SG, Weiden PJ, Loebel AD, Warrington LE et al. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. Int J Neuropsychopharmacol 2009;12:1233-1248.

  114. Rossi A, Bagalá A, Del Curatolo V, Scapati F et al. Remission in schizophrenia: one-year italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder. Human Psychopharmacology 2009;24(7):574-583.

  115. Wobrock T, Köhler J, Klein P, Falkai P. Achieving symptomatic remission in out-patients with schizophrenia – a naturalistic study with quetiapine. Acta Psychiatr Scand 2009;120:120-128.

  116. Henry LP, Amminger P, Harris MG. The EPPIC follow-up study of firsts-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J Clin Psychiatry 2010;71(6):716-728.

  117. Peuskens J, Trivedi JK, Brecher M, Miller F. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo- controlled study. Int Clin Psychopharmacology 2010;25(3):183-187.

  118. Lambert M, De Marinis T, Pfeil J, Naber D, et al. Establishing remission and good clinical functioning in schizophrenia: Predictors of best outcome with long-term risperidone long acting injectable treatment. Eur Psychiatry 2010;25:220-229.

  119. Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, et al. Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients. Schizophr Res 2010;118(1- 3):183-188.

  120. Cassidy CM, Norman R, Manchanda R, Schmitz N et al. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. Schizophr Bull 2010:36(5):1001-1008.

  121. Saravan B, Jacob KS, Johnson S, Prince M et al. Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology. Br J Psychiatry 2010;196(6):454-459.

  122. Li CT, Su TP, Chou YH, Lee YC et al. Symptomatic resolution among Chinese patients with schizophrenia and associated factors. J Formos Med Assoc 2010;109(5):378-388.

  123. Wolter A, Preuss WU, Richard KN, Mooi WW et al. Remission, prediction and stability of symptoms in schizophrenia: a naturalistic 12- monthfollow-up study. Int J Psychiatr Clin Pract 2010;14(3):160-167.

  124. Ciudad A, Bobes J, Álvarez E, San L et al. Clinical meaningful outcomes in schizophrenia: remission and recovery. Revista Psiquiatría Salud Mental 2011;4(1):53-65.

  125. Schennach-Wolf R, Seemüller F, Obermeier M, Messer T et al. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders. Eur Psychiatry 2010; DOI(10.1016).

  126. Brissos S, Videira V, Balanzá-Martinez V, Carita AI et al. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life and neurocognitive performance. Schizophr Res 2011; DOI(10.1016).

  127. Ventura J, Subotnik K, Guzik LH, Hellmann GS et al. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophr Res 2011;132:18-23.

  128. Barak Y, Swartz M. Remission amongst elderly schizophrenia patients. Eur Psychiatry 2011; DOI(10.1016).

  129. Faber G, Smid GOM H, Van Gool AR, Wunderink L et al. Neurocognition and recovery in first episode psychosis. Psychiatry Res 2011;188:1-6.

  130. Levine SZ, Rabinowitz J, Ascher-Svanum H, Faries DE et al. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study. Schizophr Res 2011;133:42-46.

  131. Girgis RR, Phillips MR, Li X, Li K et al. Clozapine v. chlorpromazine in treatment-naive,first-episode schizophrenia. 9-year outcomes of a randomized clinical trial. Br J Psychiatry 2011;199:281-288.

  132. Karow A, Moritz S, Lambert M, Schöttle D et al, on behalf of the EGOFORS initiative. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry 2012;27:401-405.

  133. Verma S, Subramaniam M, Abdin E, Poon LY, et al. Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr Scand 2012;126:282-289.

  134. Mosolov SN, Potapov AV, Ushakov UV. Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population. Ann Gen Psychiatry 2012;11(1):1-10.

  135. Barak Y, Aizenberg D. Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment. BMC Psychiatry 2012;12(108):1-5.

  136. Dahlan R, Midin M, Sidi H. Remission of symptoms among schizophrenia patients receiving assertive community treatment (ACT) in Malaysia: one year follow-up. Sains Malaysiana 2013;42:389-397.

  137. Prikryl R, Kholova M, Prikrylova Kucerova H, Ceskova E. Prevalence of remission and recovery in schizophrenia in the Czech Republic. Comp Psychiatry 2013; DOI(10.1016).

  138. Cannavó D, Concerto C, Battaglia E, Bianchini O et al. Insight and recovery in schizophrenic patients: an observational study. Clinical Neuropsychopharmacology 2013;23(1):S83-S84.

  139. Marneros A, Deister A, Rohde A et al. Long-term outcome of schizoaffective and schizophrenic disorders, a comparative study, I: Definitions, methods, psychopathological and social outcome. Eur Arch Psychiatry Clin Neurosc 1989;238:118-125.

  140. Kobayashi T. Course types of first admission schizophrenia. Seishin Igaku Clinical Psychiatry 2002;44(2):161-168.

  141. WarnerR. Recovery from schizophrenia: psychiatry and political economy. 3rd ed. Hove, UK: Brunner-Routledge; 2004.

  142. Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 2006;36(10):1349-1362.

  143. Miettunen J, Veijola J, McGrath J, Saha S et al. Recovery from schizophrenia a meta-analysis. Schizophr Res 2008;98:3-199.

  144. Crumlish N, Whitty P, Clarke M, Browne S et al. Beyond the clinical period: longitudinal study of 8 year outcome in first-episode nonaffective psychosis. Br J Psychiatry 2009;194:18-24.

  145. Strauss GP, Harrow M, Grossman LS, Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 2010;36(4):788-799.

  146. Jobe T, Harrow M. Schizophrenia course, long-term outcome, recovery, and prognosis. Current Directions Psyhcological Science 2010;19:220- 225 y 2:2145-2155.

  147. Bertelsen M, Jeppesen P, Petersen L, Thorup A et al. Course of illness in a sample of 265 patients with first-episode psychosis-five-year follow- up of the Danish opus trial. Schizophr Res 2009;107:173-178.

  148. Abdel-Baki A, Lesage A, Nicole L, Cossette M et al. Schizophrenia, an illnes with bad outcome: myth or reality?. Clin J Psychiatry 2011;56(2):92-101.

  149. Albert N, Bertelsen M, Thorup A, Petersen L et al. Predictors of recovery from psychosis analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res 2011;125:257-266.

  150. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 2012; DOI(10.1093).

  151. Harrow M, Jobe TH, Faull RN. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20- year longitudinal study. Psychol Med 2012;42:2145-2155.




2020     |     www.medigraphic.com